New Tool Helps Doctors Choose Better Epilepsy Medications
This study looked at a new online tool called EPstat, which provides doctors with real-world data about how well different epilepsy medications work for patients.
Genetics
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
What you’ll find in this topic:
- Plain-language summaries of new epilepsy studies
- What the research means for real life
- Practical questions to ask your neurologist
- Related topics you can explore next
Genetics: What Families Usually Want to Know
- What “genetic epilepsy” means (and what it doesn’t)
- When genetic testing is worth asking about
- What test results can change (treatment, prognosis, family planning)
- How to interpret “variant of uncertain significance” (VUS)
Common Genetics Terms in Plain English
- Gene variant: A change in DNA (sometimes important, often harmless)
- Pathogenic / likely pathogenic: Strong evidence it can cause disease
- VUS: Not enough evidence yet (common, may be reclassified later)
- De novo: Not inherited, happened “new” in the child
- Mosaicism: Variant exists in some cells but not others
Related Topics
Genetics FAQ
Is genetic testing only for kids?
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
If we find a gene, does it change treatment?
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
What if the result is VUS?
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Do negative results mean it’s not genetic?
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
-
-
Educating Caregivers About Sudden Unexpected Death in Epilepsy
Researchers studied how well patients with epilepsy and their caregivers understand Sudden Unexpected Death in Epilepsy (SUDEP), which is a serious risk associated with epilepsy.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Ketogenic Diet | New Studies | Pediatrics
Ketogenic Diet May Improve Seizure Control in Epilepsy
Researchers studied how the ketogenic diet (KD) affects the microbiota-gut-brain axis (MGBA) in people with drug-resistant epilepsy (DRE).
-
Comorbidities | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies | Pediatrics
Rare Gene Mutation Linked to Unusual Movement Disorder in Infants
Researchers studied a patient with unusual movement problems linked to a change in the PRRT2 gene.
-
Cenobamate Outperforms Other Medications for Focal Epilepsy
This study looked at how effective and safe four different medications—brivaracetam, cenobamate, lacosamide, and perampanel—are for adults with drug-resistant focal epilepsy.
-
Comorbidities | Devices & Neuromodulation | Epilepsy Research Summaries | Genetics | Imaging & EEG | New Studies
New Hope for Neuropsychiatric Disorders with eTNS Therapy
Researchers studied a technique called external trigeminal nerve stimulation (eTNS) to see how it might help with various neuropsychiatric disorders.
-
SCA10 Patients Show Brain Connectivity Changes and Atrophy
This study looked at people with spinocerebellar ataxia type 10 (SCA10), a rare genetic condition that affects movement and can cause seizures.
-
KCNH Mutations Linked to Epilepsy and Developmental Disorders
Researchers studied how certain genetic mutations in two proteins, KCNH1 and KCNH5, are linked to epilepsy and developmental disorders.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Imaging & EEG | New Studies | Pediatrics
New Framework for Evaluating Pediatric Movement Disorders Before Surgery
Researchers studied how children with movement disorders, specifically those with severe muscle stiffness (known as hypertonia), are evaluated before undergoing neurosurgery.
